Skip to Main content Skip to Navigation
Journal articles

Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates

Abstract : Liver-directed gene therapy for the coagulation disorder hemophilia showed safe and effective results in clinical trials using adeno-associated viral vectors to replace a functional coagulation factor, although some unmet needs remain. Lentiviral vectors (LVs) may address some of these hurdles because of their potential for stable expression and the low prevalence of preexisting viral immunity in humans. However, systemic LV administration to hemophilic dogs was associated to mild acute toxicity and low efficacy at the administered doses. Here, exploiting intravital microscopy and LV surface engineering, we report a major role of the human phagocytosis inhibitor CD47, incorporated into LV cell membrane, in protecting LVs from uptake by professional phagocytes and innate immune sensing, thus favoring biodistribution to hepatocytes after systemic administration. By enforcing high CD47 surface content, we generated phagocytosis-shielded LVs which, upon intravenous administration to nonhuman primates, showed selective liver and spleen targeting and enhanced hepatocyte gene transfer compared to parental LV, reaching supraphysiological activity of human coagulation factor IX, the protein encoded by the transgene, without signs of toxicity or clonal expansion of transduced cells.
Document type :
Journal articles
Complete list of metadatas

Cited literature [59 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02430990
Contributor : Nicolas Jaulin <>
Submitted on : Tuesday, January 7, 2020 - 4:27:13 PM
Last modification on : Friday, June 19, 2020 - 9:28:02 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Michela Milani, Andrea Annoni, Federica Moalli, Tongyao Liu, Daniela Cesana, et al.. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Science Translational Medicine, American Association for the Advancement of Science, 2019, 11 (493), pp.eaav7325. ⟨10.1126/scitranslmed.aav7325⟩. ⟨inserm-02430990⟩

Share

Metrics

Record views

126